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Aims The aim was to validate, update, and extend the Diamond–Forrester model for estimating the probability of obstruc-
tive coronary artery disease (CAD) in a contemporary cohort.
Methods
and results
Prospectively collected data from 14 hospitals on patients with chest pain without a history of CAD and referred for
conventional coronary angiography (CCA) were used. Primary outcome was obstructive CAD, defined as ≥50% ste-
nosis in one or more vessels on CCA. The validity of the Diamond–Forrester model was assessed using calibration
plots, calibration-in-the-large, and recalibration in logistic regression. The model was subsequently updated and
extended by revising the predictive value of age, sex, and type of chest pain. Diagnostic performance was assessed
by calculating the area under the receiver operating characteristic curve (c-statistic) and reclassification was deter-
mined. We included 2260 patients, of whom 1319 had obstructive CAD on CCA. Validation demonstrated an over-
estimation of the CAD probability, especially in women. The updated and extended models demonstrated a c-statistic
of 0.79 (95% CI 0.77–0.81) and 0.82 (95% CI 0.80–0.84), respectively. Sixteen per cent of men and 64% of women
were correctly reclassified. The predicted probability of obstructive CAD ranged from 10% for 50-year-old females
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with non-specific chest pain to 91% for 80-year-old males with typical chest pain. Predictions varied across hospitals
due to differences in disease prevalence.
Conclusion Our results suggest that the Diamond–Forrester model overestimates the probability of CAD especially in women.
We updated the predictive effects of age, sex, type of chest pain, and hospital setting which improved model per-
formance and we extended it to include patients of 70 years and older.
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Introduction
In patients presenting with chest pain suggestive of stable angina
pectoris, numerous diagnostic strategies can be used. The refer-
ence standard for diagnosing coronary artery disease (CAD) is
conventional coronary angiography (CCA). However, CCA is
expensive and involves a small risk of complications and death.1
Therefore, non-invasive testing is recommended to select patients
who will benefit from CCA.2– 4 The clinical value of non-invasive
diagnostic tests depends on the test sensitivity, the specificity,
the potential gain from making the correct diagnosis, the potential
harm caused by false-positive test results, and the pre-test (prior)
probability of the suspected disease.5 – 7 In choosing the appropri-
ate test for a particular patient with chest pain suggestive of CAD,
the pre-test probability of CAD is crucial.7
Diamond and Forrester8 demonstrated the importance of the
pre-test probability on interpreting test results in their classic
paper in 1979. Using estimates from autopsy and cross-sectional
studies, they developed a simple but elegant model that considers
age, sex, and type of chest pain to estimate the probability of
obstructive CAD in patients between 30 and 70 years old. In
spite of its limitations, the Diamond–Forrester model is still
used in current guidelines.2– 4 Although other cardiovascular risk
factors such as diabetes, smoking and dyslipidaemia have been
included in, e.g. the Duke Clinical Score,9,10 the predictive effects
of other risk factors in diagnostic models are often small compared
with the predictive effects of age, sex, and type of chest pain. Fur-
thermore, complicated models are less likely to be used by phys-
icians in clinical practice especially since non-invasive diagnostic
tests are commonly ordered immediately at the first visit. The
Diamond–Forrester model allows the immediate calculation of
an estimate of the patients’ pre-test risk of CAD, without the
need to wait for laboratory findings or exercise test results.
Since the Diamond–Forrester model was developed .30 years
ago and based on data from the USA only, our aims were to study
the validity of the Diamond–Forrester predictions in estimating
the probability of obstructive CAD, to update the predictions
using recently collected data, and to extend the model for patients
beyond the age of 70, using data from contemporary cohorts.
Methods
The CAD Consortium
The CAD Consortium is part of the European network for the Assess-
ment of Imaging in Medicine (EuroAIM), which is an initiative of the
European Institute of Biomedical Imaging Research (EIBIR).11 The
main goal of EuroAIM is to perform pooled analyses of existing pro-
spectively collected data, which will improve power of the studies
and increase generalizability of the results obtained.
Data collection
A consortium of researchers from various countries in Europe and the
USA was formed. An existing database with prospectively collected
data on 80 or more eligible patients was required for participation in
this consortium. All patients included in this consortium had to be
enrolled in single-centre studies, for which local approval from the Insti-
tutional Review Board and signed informed consent had been obtained.
Participation in the consortium did not involve any financial incentives.
Patient population
Our patient population consists of patients with chest pain, suggestive
of stable angina pectoris. Patients were eligible for the analysis if they
presented with stable chest pain (typical, atypical, or non-specific chest
pain) and if CCA was performed. Patients were excluded if they met
one of the following criteria: (i) acute coronary syndrome or unstable
chest pain, (ii) history of myocardial infarction or previous revascular-
ization (percutaneous coronary intervention or coronary artery bypass
graft surgery), and (iii) no informed consent.
Only patients who underwent CCA were eligible for this analysis,
implying that our population was highly selected. To explore the
effect of selection bias (i.e. verification bias) in this study population,
we performed a separate analysis using inverse probability weighting
on each patient in the data set. Based on an independent registry
data set (not included in our consortium) consisting of unselected out-
patients presenting to the cardiologist who were intended to undergo
both stress-ECG and coronary CT angiography (CCTA) for the evalu-
ation of chest pain,12,13 a logistic regression analysis was performed to
calculate the probability of undergoing CCA (i.e. the probability of ver-
ifying the presence of CAD with CCA) depending on age, sex, and type
of chest pain. Each patient was subsequently weighted with the inverse
of the probability of verification which corrects for verification bias
(Appendix, Correction for verification bias).14,15
Clinical definitions
Data on age, sex, type of chest pain, and the presence of CAD were
collected. Type of chest pain was classified as being typical, atypical,
or non-specific. Typical chest pain was defined as having (i) substernal
chest pain or discomfort, that is (ii) provoked by exertion or emotional
stress and (iii) relieved by rest and/or nitroglycerine. Atypical chest
pain was defined as having two of the before-mentioned criteria. If
one or none of the criteria was present, the patient was classified as
having non-specific chest pain.4,16
The presence of obstructive CAD was defined as one or more
vessels with ≥50% lumen diameter reduction on CCA. As we used
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existing databases, CCA was performed at each institution according
to local protocols; both visual assessment and quantitative assessment
were allowed for interpretation of the CCA. Indicator variables for
hospital were used to allow adjustment for hospital.
Data analysis
Validation and updating of the Diamond–Forrester model was per-
formed using state-of-the-art methods,17–19 by one of the authors
(T.S.S.G.). See Appendix for a more detailed description of the methods.
Validation
The Diamond–Forrester model takes into account age, sex, and type
of chest pain and was developed for patients between 30 and 70 years.
For validation, we therefore excluded both patients below the age of
30 and patients above the age of 69.
The observed frequency of CAD in our data set was calculated stra-
tifying for 10-year age category, sex, and type of chest pain (i.e. equiv-
alent to the Diamond–Forrester categories). Observed frequencies of
CAD were compared with the estimates according to Diamond
and Forrester and subsequently tabulated and presented by means
of calibration plots.
Calibration-in-the-large
When assessing the validity of a prediction model, the first step is to
check whether the average prediction is equal or close to the
average observed outcome. This concept is referred to as
‘calibration-in-the-large’. Hereto, we compared the mean observed
frequency of CAD with the mean prediction according to Diamond
and Forrester.
Recalibration
The second step is to test whether the overall effect of the predictors
in the Diamond–Forrester model is valid for the consortium data.
Re-estimation
The third step is to re-estimate the predictor effects in the consortium
data and to compare the effects with the original effects according to
Diamond and Forrester. Subsequently, we calculated the difference
between the re-estimated and the original effects (Appendix, Table A1).
Updating and extension
For updating the Diamond–Forrester model, we used all data including
patients ,30 and .69 years. Age, sex, and type of chest pain were
entered simultaneously in a logistic regression model. All analyses
were performed both unadjusted and adjusted for hospital.
Separately, we extended the model with a random intercept to
allow for heterogeneity in CAD prevalence across different hospitals
(Appendix, Table A3). Because of potential differences in symptom
classification across hospitals, we also tested random effects for type
of chest pain between different hospitals.
Diagnostic performance was quantified by calculating the area under
the receiver operating curve (c-statistic). Calibration was assessed
using the Hosmer–Lemeshow goodness-of-fit test and a calibration
plot (Appendix, Figure A2).
Reclassification was assessed by cross-tabulating the probability classi-
fication of patients according to the Diamond–Forrester model vs. the
updated model. We analysed reclassification with the commonly used
cutoffs of 30 and 70% (Appendix, Table A4, A6).20 In a second reclassifi-
cation analysis, we analysed the cutoff 40% (Appendix, Table A5, A7),
which is the threshold below which CCTA is cost-effective.7 Further-
more, we determined the reclassification calibration statistic and the
net reclassification improvement (Appendix, Table A8).21,22
Validation of the updated model
As mentioned, the CAD Consortium population is highly selected
based on referral to CCA. To assess the performance of the
updated model in a low-risk population, we validated the updated
model in an independent data set (not included in our consortium)
consisting of outpatients presenting to the cardiologist who were
intended to undergo both stress-ECG and CCTA for the evaluation
of chest pain.12,13 These data were also used to perform the ‘correc-
tion for verification bias’. We followed the step-wise approach as
described above. Since not all patients in this population underwent
CCA, the CCTA results were used as a proxy for the reference stan-
dard in patients who did not undergo CCA.
A P-value ,0.05 was considered statistically significant. Statistical
analyses were performed using Stata/SE 10.1 (StataCorp, TX, USA).
Reclassification was assessed by using syntax made available by Cook
et al.22 in SAS Enterprise Guide v3 (SAS, Inc., NC, USA).
Results
Data collection and study population
Existing databases with prospectively collected data were retrieved
from 14 hospitals (Table 1). After excluding 12 cases because of
missing values, the total study population consisted of 2260
patients [1521 men, 739 women, mean age 62 (range 21–93,
IQR 55–70)], of whom 1319 (58.4%) were found to have
obstructive CAD on CCA.
For validation, we excluded patients below the age of 30 (n ¼ 7)
and above the age of 69 (n ¼ 570). Therefore, 1683 patients [1159
(68.9%) men, 524 women] and 937 (55.7%) with obstructive CAD
were left for validation.
Data analysis
Validation
Table 2 and Figures 1 and 2 show the average observed frequency
of CAD in men and women, respectively, as observed in our data
set, compared with the prediction according to Diamond and For-
rester. In men, we observed a slight overestimation of the prob-
ability of CAD by Diamond and Forrester for patients with
atypical and typical chest pain. In women, the overestimation was
more pronounced. The validation of predictions for men ,40
and women ,50 years old was less reliable, due to the limited
number of patients in these subgroups.
Calibration-in-the-large
We found that the average predicted probability according to
Diamond and Forrester was higher compared with the CAD
frequency in the consortium data (P, 0.001).
Recalibration
Recalibration demonstrated that the overall effect of the predic-
tors in the Diamond–Forrester model was higher compared
with the overall effect of the predictors in the consortium data
(P, 0.001).
Re-estimation
The effects of age (P, 0.001) and type of chest pain (P, 0.001)
were significantly larger in the Diamond–Forrester model,
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Table 1 Patient characteristics, ordered according to the prevalence of coronary artery disease
Hospital, country
Medical
University of
South Carolina,
Charleston,
USA
Turku University
Hospital, Finland
Innsbru¨ck
Medical
University,
Austria
Maasstad
Ziekenhuis,
Rotterdam,
The
Netherlands
Leiden University
Medical Center,
The Netherlands
Erasmus
University
Medical
Center, The
Netherlands
Charite´
Medical
School,
Berlin,
Germany
University
Medical Center
Utrecht, The
Netherlands
Papworth
Hospital NHS
Foundation
Trust,
Cambridge, UK
n 99 98 101 90 99 289 186 85 83
Mean age (SD) 60.3 (10.4) 64.4 (6.8) 61.2 (8.6) 59.0 (9.9) 62.1 (10.9) 59.4 (10.6) 62.7 (9.4) 60.5 (5.4) 65.5 (10.8)
Male sex (%) 49.5 58.2 58.4 58.9 56.6 68.5 71.0 67.1 65.1
Typical CP (%) 76.8 50.0 21.8 10.0 62.6 50.2 57.0 55.3 41.0
Atypical CP (%) 20.2 42.9 78.2 27.8 35.4 26.0 29.0 18.8 36.1
Non-specific CP (%) 3.0 7.1 0 62.2 2.0 23.9 14.0 25.9 22.9
CAD on CCA (%) 39.4 42.9 45.5 50.0 51.5 52.2 54.8 57.6 59.0
Hospital, country University
Hospital
Parma, Italy
The Essex
Cardiothoracic
Centre, UK
University
Hospital
Leuven,
Belgium
University
Hospital
Zurich,
Switzerland
Federal Center for
Medicine and
Rehabilitation,
Moscow, Russia
Total
(CAD1)
Total (CAD2) Total
n 277 110 100 549 106 1325 947 2272
Mean age (SD) 59.9 (11.4) 63.2 (9.5) 64.0 (10.7) 65.6 (10.9) 59.7 (8.4) 63.8 60.3 (10.9) 62.3 (10.4)
Male sex (%) 67.9 68.2 59.0 74.5 76.4 78.0 52.2 67.2
Typical CP (%) 65.0 52.7 58.0 53.4 56.6 69.3 30.2 53.0
Atypical CP (%) 35.0 24.5 28.0 10.9 24.5 19.1 37.3 26.7
Non-specific CP (%) 0 22.7 14.0 35.7 18.9 11.6 32.5 20.3
CAD on CCA (%) 60.0 61.8 63.0 68.1 75.5 100 0 58.3
SD, standard deviation; CP, chest pain; CAD, coronary artery disease; CCA, conventional coronary angiography.
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Table 2 Head-to-head comparison of the pre-test probability according to Diamond and Forrester
Men Women
Diamond
and
Forrester
Observed
frequency
of CAD
Updated
modela
Diamond
and
Forrester
Observed
frequency
of CAD
Updated
modela
Typical chest pain
30–39 69.7 90.0 59.1 25.8 b 27.5
40–49 87.3 73.2 68.9 55.2 41.4 36.7
50–59 92.0 82.0 77.3 79.4 38.5 47.1
60–69 94.3 86.1 83.9 90.6 56.9 57.7
70–79 — 88.6 88.9 — 70.8 67.7
.80 — 86.2 92.5 — 92.3 76.3
Atypical chest pain
30–39 21.8 16.7 28.9 4.2 b 9.6
40–49 46.1 28.9 38.4 13.3 19.2 14.0
50–59 58.9 45.9 48.9 32.4 24.2 20.0
60–69 67.1 53.9 59.4 54.4 30.1 27.7
70–79 — 63.6 69.2 — 35.6 37.0
.80 — 83.3 77.5 — b 47.4
Non-anginal chest pain
30–39 5.2 14.3 17.7 0.8 b 5.3
40–49 14.1 20.9 24.8 2.8 0.0 8.0
50–59 21.5 28.6 33.6 8.4 22.2 11.7
60–69 28.1 50.5 43.7 18.6 18.0 16.9
70–79 — 62.1 54.4 — 22.0 23.8
.80 — 45.0 64.6 — 20.0 32.3
The observed frequency of CAD in the CAD consortium data and the prediction according to the updated model. Subgroup estimates that are overestimated by the Diamond–
Forrester model are printed in boldface.
aProbabilities shown reflect the estimates for patients aged 35, 45, 55, 65, 75, and 85 years.
bData on subgroups with less than five observations are not shown.
Figure 1 Predicted probability of obstructive coronary artery disease in men (triangles) for the Diamond–Forrester age categories a: 30–39,
b: 40–49, c: 50–59, and d: 60–69, vs. the observed frequency of obstructive coronary artery disease in our data. The legend provides the
number of patients per age category for each type of chest pain. The bars indicate the 95% confidence interval of the observed frequency.
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compared with the effects in the consortium data. We conclude
that these predictors require updating.
Updating and extension
The updated model (Table 3) showed highly significant effects for
age, sex, and type of chest pain, with similar effect sizes after
adjustment for hospital (not shown). The area under the receiver
operating characteristic curve demonstrated good performance
(c-statistic: 0.79, 95 CI: 0.77–0.81). After correction for verification
bias, the regression coefficients were similar (Appendix, Table A3).
Interactions between the main effects did not show statistical
significance (not shown). We found significant interactions
between ‘typical chest pain’ and hospital (not shown), implying
that the effect of having typical chest pain on the predicted prob-
ability is different across hospitals.
Finally, a random effects logistic regression model showed that
there was substantial heterogeneity in disease prevalence across
hospitals. The model could not be improved by adding a random
effect for atypical chest pain, whereas a random effect for typical
chest pain showed statistical significance (Appendix, Table A3).
The random effects model is available for online use (Figure 3).
The test for a non-linear age effect was not statistically significant,
which is why we assumed a linear effect for age in all models.
Analysis of reclassification in 30–69-year-old patients demon-
strated that 16% of men and 64% of women reclassified cor-
rectly, when using the probability categories ,30, ≥30–70,
and ≥70% (Figures 4 and 5). The net reclassification index was
negative for both men and women, which is explained by the
fact that the updated model predicts less high probabilities com-
pared with Diamond and Forrester, resulting in down-
classification of patients among both cases and non-cases
(Appendix, Table A8).
Validation of the updated model
Calibration-in-the-large
The average predicted probability according to our updated model
was significantly higher compared with the CAD frequency in the
independent data set (P, 0.001).
Recalibration
Recalibration demonstrated that the overall effect of the predic-
tors in the updated model is similar to the overall effect of the pre-
dictors in the independent registry of outpatients (P ¼ 0.79). From
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Table 3 Updating and extension of the Diamond–
Forrester model (random effects model)
Coefficient Odds
ratio
95 % CI
lower
limit
95 % CI
upper
limit
Age 0.04 1.04 1.03 1.05
Male sex 1.34 3.82 3.08 4.74
Typical chest
pain
1.91 6.72 3.97 11.37
Atypical chest
pain
0.64 1.89 1.38 2.59
Non-specific
chest paina
— —
Intercept 24.37 —
c-Statistic
(95% CIb)
0.82 0.80 0.84
aReference category.
bEstimated by bootstrapping with 1000 repetitions.
Figure 2 Predicted probability of obstructive coronary artery disease in women (circles) for the Diamond–Forrester age categories a: 30–
39, b: 40–49, c: 50–59, and d: 60–69, vs. the observed frequency of obstructive coronary artery disease in our data. The legend provides the
number of patients per age category for each type of chest pain. Data on subgroups with less than five observations are not shown. The bars
indicate the 95% confidence interval of the observed frequency.
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this, we conclude that the predictor effects are valid and do not
require updating (Appendix, Table A9).
The model, adjusted for the lower disease prevalence, is avail-
able for online use (Figure 3).
Discussion
Using recently collected data and modern statistical methods, we
assessed whether the Diamond–Forrester model is valid in a con-
temporary mainly European cohort (Box 1). Furthermore, we
updated and extended the model by re-estimating the predictive
effects of age, sex, and type of chest pain. We observed that the
prevalence of CAD was different across hospitals and adjusted
for this difference.
Box 1 Study strengths and weaknesses
Strengths
† A large contemporary cohort was studied.
† Multicentre collaboration of 14 hospitals.
† Modern statistical methods were used for validation,
updating, and extension of the Diamond–Forrester
model.
† In contrast to the Diamond–Forrester model, the
updated model uses age as a continuous predictor and
also predicts probabilities for patients 70 years and older.
† An easy-to-use online probability calculator was
developed.
Weaknesses
† Only age, sex, and type of chest pain were considered
predictors.
† The primary outcome was limited to obstructive CAD vs.
no obstructive CAD.
† Existing databases designed for other research objectives
were combined.
† A high-risk population was selected by including only
patients referred for coronary angiography.
† Heterogeneity across hospitals with respect to the assess-
ment of chest pain, adherence to guidelines, and
interpretation of the coronary angiographies.
In short, we validated the Diamond–Forrester predictions in
patients between 30 and 70 years old. By comparing the
Diamond–Forrester predicted probabilities with the average
observed frequencies of obstructive CAD in our data using cali-
bration plots, we demonstrated that there is a tendency for the
Diamond–Forrester model to overestimate the prevalence of
CAD in a contemporary cohort. We showed that the
Diamond–Forrester model needs to be updated according to
the overall disease prevalence for the current European situation.
Furthermore, we demonstrated that the predictor effects in the
consortium data are not as extreme as the model by Diamond
and Forrester suggests.
It is important to note that the Diamond–Forrester model is
based on 30–40-year-old data from the USA. To some extent,
Figure 3 Online calculator example. Here, the probability of
obstructive coronary artery disease is calculated for a
60-year-old male with typical chest pain. The calculator is
based on the random effects model (Table 3) and is available
for online use via http://rcc.simpal.com/RCEval.cgi?Owner=
tgenders&RCName=CAD%20consortium. The recalibrated
model for the low-risk populations is available via http://rcc.
simpal.com/RCEval.cgi?RCID=7TO293.
Figure 5 Reclassification flow chart for women between 30
and 70 years old. See Appendix, Table A8 for reclassification
statistics.
Figure 4 Reclassification flow chart for men between 30 and
70 years old. See Appendix, Table A8 for reclassification statistics.
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the differences we demonstrated are explained by changes in the
risk factor distributions over the past decades, as well as by the
differences between populations from the USA and Europe.
All-in-all, we demonstrated that the validity of the Diamond–
Forrester model for current practice is limited, which justifies
updating. Furthermore, Diamond and Forrester did not provide
any estimates for patients above the age of 69. Nowadays, a
substantial proportion of patients with chest pain will be at
least 70 years old, which motivated the extension of the
Diamond–Forrester model. Therefore, we re-estimated the pre-
dictive effect of age, sex, and type of chest pain in all patients
and confirmed the importance of these in the prediction of
obstructive CAD. We also demonstrated that predictions may
vary across different hospitals. The performance of the updated
model improved discrimination and calibration, as indicated by
the c-statistic and the non-significant Hosmer–Lemeshow test.
Measures of reclassification indicated correct reclassification by
the updated model of a substantial proportion of patients,
especially in women. Updated predicted probabilities of obstruc-
tive CAD ranged from 10% for a 50-year-old female with non-
specific chest pain to 91% for an 80-year-old man with typical
chest pain. Prior studies assessed the performance of the
Diamond–Forrester model23 or developed new models to esti-
mate the pre-test probability of CAD.9,10,24 However, in spite of
efforts to develop new prediction models, the Diamond–Forrester
model remains a common method for estimating the probability of
obstructive CAD.2,4
Limitations
The study population was derived from existing databases, some of
which were designed for other research objectives (e.g. to investi-
gate the diagnostic accuracy of non-invasive imaging tests for
CAD). In some studies, all patients underwent the reference stan-
dard test, whereas in other studies, patients were selected for
CCA based on the results of an index non-invasive test. When
evaluating the diagnostic performance of the index non-invasive
test, selection based on the test results may lead to ‘verification
bias’ or ‘referral bias’ which may bias estimates of sensitivity and
specificity of such a test. In the current study, however, we did
not assess the diagnostic performance of a non-invasive test,
making bias less likely. To explore the potential effect of verifica-
tion bias, we used inverse probability weighting on each individual
with the probability of verification based on age, sex, and type of
chest pain. The analyses with or without correction for verification
bias yielded similar results, indicating that our results are unlikely to
be biased by selected verification.
The fact that we only included patients who underwent CCA
indicates the selection process that occurred in this study. Some
of the patients will have had prior positive stress testing or
another non-invasive imaging test. However, the association
between age, sex, type of chest pain, and the presence of obstruc-
tive CAD on CCA does not depend on whether another diagnos-
tic imaging test was performed and whether it was positive or not.
The elderly, males, and patients with typical chest pain are more
likely to undergo stress testing. Such patients are therefore over-
represented in our population. Incorporating the test results
from the non-invasive test in the prediction model would influence
the prediction of the probability of obstructive CAD. However,
our aim was to predict the presence of obstructive CAD on
initial presentation prior to diagnostic testing to provide decision
support for the decision to test.
The presence of obstructive CAD was determined by CCA.
As existing databases were used, CCAs were carried out at each
individual hospital according to local protocols. Some institutions
used quantitative coronary angiography to determine the degree
of stenosis, whereas others used visual assessment. All in all, het-
erogeneity due to differences between protocols and guidelines
across hospitals could have influenced our results.
One could argue that our study population does not represent
the target population of the Diamond–Forrester model because of
the high prevalence of CAD. It might be more reasonable to apply
the model in patients without a clinical indication for CCA and a
lower probability of disease. However, despite the overall high
prevalence of disease in our study population, we showed that
the Diamond–Forrester model tends to overestimate the prob-
ability of CAD. The overestimation will be even larger, if the
model would be applied to lower risk populations. As expected,
validation of the updated model in the independent data consisting
of outpatients presenting with chest pain demonstrated an overes-
timation of the probability of CAD, although to a lesser extent
than the overestimation by Diamond and Forrester would be.
Recalibration results did not justify updating of the predictor
effects, suggesting that after adjusting the intercept, our updated
model would be valid for the estimation of the pre-test probability
of CAD in this low-risk population.
Furthermore, the Diamond–Forrester model predicts the prob-
ability of the presence vs. the absence of obstructive CAD. In vali-
dation and updating, we focused on this dichotomous outcome.
This is a limitation of our study design, since detecting severe
CAD (e.g. ≥70% stenosis, multi-vessel disease, left main disease)
would have different clinical implications, as those patients would
be eligible for revascularization.
Although our total sample size was large, some analyses involved
stratification for several variables. This resulted in small numbers of
patients in the lower age categories, especially for women because
women represented only 30% of the total population.
Clinical implications
According to our analysis, the Diamond–Forrester model overes-
timates the probability of obstructive CAD in a contemporary
cohort. Thus, the pre-test probability for today’s patients can be
estimated with more precision if the updated model is used.
The clinical value of a diagnostic test depends largely on the
pre-test probability. A better estimate of the pre-test probability
will therefore help clinicians make better decisions as to whether
and which diagnostic test is indicated in a particular patient and
to decide on further management based on the results of such
tests. In patients with a (very) low pre-test probability of disease,
a wait-and-see strategy without any testing is preferable. In patients
with a high pre-test probability of disease, a direct invasive strategy
is optimal. The main benefit of testing is in patients with an inter-
mediate pre-test probability, in which a negative test rules out the
presence of obstructive CAD, whereas a positive test justifies
further testing.
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Since the updated model predicts less high probabilities com-
pared with the Diamond–Forrester model, using the updated
model could lead to decreased referral to CCA, a higher yield of
angiography, and increased use of non-invasive testing for risk stra-
tification. This would be a welcome response to the issue brought
to light by Patel et al.,25 who reported that the diagnostic yield of
elective coronary angiography in the USA was only 41% (i.e. only
41% was found to have obstructive CAD) and concluded that
better risk-stratification tools are needed.
Finally, the revised model is user-friendly and requires only three
inputs from the physician. The model can be used via the website,
or it could be implemented in electronic patient records or elec-
tronic order entry systems.
Future research
Our study focused on the prediction of obstructive CAD accord-
ing to age, sex, type of chest pain, and hospital only. Other risk
factors such as smoking, diabetes, hypertension and dyslipidaemia
have previously been demonstrated to be associated with the pres-
ence of CAD.26 Therefore, other known cardiovascular risk factors
should be considered in future prediction models. On the other
hand, the predictive effects of cardiovascular risk factors (in diag-
nostic models) are probably small in comparison with the predic-
tive effects of age, sex, and type of chest pain, and care should be
taken to minimize the number of variables, because simple predic-
tion tools are more likely to be used by physicians in clinical
practice.
Prospective data should be collected for the development and
validation of prediction models, including a more heterogeneous
study population. For example, including populations with a
lower overall probability of obstructive CAD would improve the
generalizability of the results.
Conclusion
All-in-all, we updated and extended the predictive effects of age,
sex, and type of chest pain, based on a contemporary cohort
and using modern statistical methods. We demonstrated that the
Diamond–Forrester model can be improved for the current
European situation. The updated model is available online.
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Appendix
Validation and updating of the Diamond–Forrester model was
performed by T.S.S.G., using state-of-the-art methods.17–19
Validation
The Diamond–Forrester model takes into account age, sex, and
type of chest pain and was designed for patients between 30 and
70 years only. For the validation of the Diamond–Forrester
model, we therefore excluded both patients below the age of 30
and patients above the age of 69.
‘Original’ Diamond–Forrester coefficients
The Diamond–Forrester model8 is based on a Bayesian analysis.
Therefore, it does not provide regression coefficients for the
effects of age, sex, and type of chest pain on the probability of
CAD. To unravel the implicit coefficients of the predictors in
this model, we performed a weighted linear regression on the
log odds of the Diamond–Forrester predictions per subgroup.
The weights were proportional to the inverse of the standard
errors reported by Diamond and Forrester. The coefficients
obtained by the weighted linear regression are further referred
to as the ‘original coefficients’ of Diamond and Forrester.
The observed frequency of CAD in our data set was calculated
stratifying for 10-year age category, sex, and type of chest pain (i.e.
equivalent to the Diamond–Forrester categories). Observed fre-
quencies of CAD were compared with the predicted probabilities
of CAD according to Diamond and Forrester and were sub-
sequently tabulated (Table 2) and presented by means of cali-
bration plots (Figures 1 and 2).
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Calibration-in-the-large
In the consortium data, patients aged 30–69 (Diamond–Forrester
age range) were assigned the log odds of obstructive CAD as esti-
mated by the weighted linear regression model, i.e. the linear pre-
dictor. A model (Equation 1 in Figure A1) was fitted to calculate the
log odds of obstructive CAD as observed in our data set. The
linear predictor of Diamond and Forrester (lpD&F) was included
in the model and its coefficient was fixed at unity. In this way,
the original absolute and relative effects of the original
Diamond–Forrester model are maintained. The intercept (anew)
is the only free parameter in the model, which allows us to quantify
the ‘calibration-in-the-large’ and adjust for difference in disease
prevalence. The intercept (anew) can be interpreted as the differ-
ence in log odds between the mean observed outcome and the
mean predicted probability of CAD according to Diamond and
Forrester.19 In other words, we assessed calibration-in-the-large
by comparing the mean observed frequency of CAD with the
Figure A1 Equations. Logit, natural log odds of the probability; pCAD, probability of obstructive coronary artery disease; a, intercept of
logistic regression model; offset, regression coefficient fixed at unity; b, regression coefficient; d, difference between bnew and boriginal (See
Table A1 for ‘original’ coefficients); lpD&F, linear predictor of Diamond and Forrester; *, random effect.
Figure A2 Calibration plot of the updated model (See Table
A3, Model 1).
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Table A1 Validation of the Diamond–Forrester model
Model Diamond and Forrester (weighted linear
regressiona) ‘original’ regression coefficients
d coefficientsb (Equation 3 in Figure A1)
(in patients aged 30–69, n 5 1683)
Coefficient P-value Coefficient P-value
Baseline analysis a 27.52 — d a 2.97 ,0.001
Age 0.09 — d Age 20.04 ,0.001
Male sex 1.35 — d Male sex 0.05 0.67
Typical CP 3.77 — d Typical CP 21.78 ,0.001
Atypical CP 1.70 — d Atypical CP 21.20 ,0.001
c-Statistic (95% CIc) 0.78 (0.76–0.79) 0.78 (0.76–0.81)
HL P-value ,0.001 0.36
Analyses adjusted for hospitald d a 2.05 ,0.001
d Age 20.04 ,0.001
d Male sex 20.02 0.88
d Typical CP 21.21 ,0.001
d Atypical CP 20.96 ,0.001
c-Statistic (95% CIc) 0.81 (0.79–0.83)
HL P-value 0.06
CP, chest pain; HL, Hosmer–Lemeshow goodness-of-fit test (significant result indicates lack of model fit, poor calibration); a, intercept; lpD&F, linear predictor of Diamond and
Forrester.
aRegression coefficients were approximated by weighted linear regression (see Appendix, Original Diamond-Forrester coefficients).
bDifference between Diamond–Forrester coefficients and refitted coefficients.
cEstimated by bootstrapping with 1000 repetitions.
dReference category is Erasmus University Medical Center.
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mean of the predicted probabilities according to Diamond and
Forrester in a logistic regression model. We tested whether the
difference (i.e. the intercept) was significantly different from zero.
Recalibration
Next, we recalibrated the model by comparing the average
regression slope of Diamond and Forrester with the average
regression slope in the consortium data. A second linear predictor
variable was added to the model (while maintaining both the pre-
vious linear predictor as offset variable and the new intercept), and
its coefficient bmiscalibration (Equation 2 in Figure A1) was estimated.
This coefficient reflects the miscalibration of the Diamond–Forres-
ter predictor effects when compared with the predictor effects in
the consortium data.19 We tested whether bmiscalibration ¼ 0, cor-
responding to the hypothesis that the Diamond–Forrester predic-
tion (adjusted for calibration-in-the-large) fits the data well. If
significant, we conclude that the overall effects of age, sex, and
type of chest pain together are different in our data and that
model revision is justified.
Re-estimation
Finally, we re-estimated the predictor effects in a model including
the linear predictor as offset and the new intercept (Equation 3 in
Figure A1). The coefficients from this analysis refer to the difference
between the re-estimated and the original coefficients (i.e.
d-coefficients). We tested whether these differences were signifi-
cantly different from zero. From these analyses, we can judge
which predictor effects are different in our data compared with
the model according to Diamond and Forrester.
All analyses were performed both unadjusted and adjusted for
hospital.
Updating and extension
To update the Diamond–Forrester model, we performed a logis-
tic regression analysis (Equation 4 in Figure A1), using all data,
including patients below the age of 30 and above the age of 69.
All variables (age, sex, and type of chest pain) were entered sim-
ultaneously in the model (‘baseline analysis’) (Table A3). To judge
whether interaction terms should be considered, we performed
an overall test for interaction using second-order interactions of
the main effects (i.e. age, sex, and type of chest pain). Significant
interaction terms were tested one-by-one and omitted if non-
significant. Similarly, interactions between main effects and hospital
were tested.
Separately, we extended the model with a random intercept
to allow for heterogeneity in CAD prevalence across different
hospitals (Equation 5 in Figure A1). Because of potential differ-
ences in symptom classification across hospitals, we also
tested random effects for type of chest pain across different hos-
pitals (Equation 6 in Figure A1). The linearity assumption for the
continuous variable age was checked graphically and tested stat-
istically by including a restricted cubic spline function (with three
knots (2 d.f.).
Diagnostic performance was quantified by calculating the area
under the receiver operating curve (c-statistic), and confidence
intervals were obtained by bootstrapping with 1000 repetitions.
Calibration was estimated by the Hosmer–Lemeshow goodness-
of-fit test and by constructing a calibration plot (Figure A2).
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Table A3 Updating and extension of the Diamond–
Forrester model
Coefficient Odds
ratio
95% CI
lower
limit
95% CI
upper
limit
Model 1: Baseline analysis
Age 0.04 1.04 1.03 1.05
Male sex 1.34 3.82 3.11 4.70
Typical chest pain 1.99 7.33 5.69 9.43
Atypical chest pain 0.50 1.65 1.26 2.16
Non-specific chest
paina
— —
Intercept 24.32 —
c-Statistic (95% CIb) 0.79 0.77 0.81
HL P-value 0.52
Model 2: Corrected for verification bias
Age 0.04 1.04 1.02 1.06
Male sex 1.16 3.20 2.47 4.15
Typical chest pain 1.99 7.31 5.62 9.52
Atypical chest pain 0.63 1.87 1.40 2.51
Non-specific chest
paina
— —
Intercept 24.09 —
c-Statistic (95% CIb) 0.78 0.76 0.80
Model 3: Random intercept + random slope ‘typical chest pain’c
Age 0.04 1.04 1.03 1.05
Male sex 1.34 3.82 3.08 4.74
Typical chest pain 1.91 6.72 3.97 11.37
Atypical chest pain 0.64 1.89 1.38 2.59
Non-specific chest
paina
— —
Intercept 24.37 —
c-Statistic (95% CIb) 0.82 0.80 0.84
aReference category.
bEstimated by bootstrapping with 1000 repetitions.
cGroup variable is ‘hospital’.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table A2 Logistic regression predicting the probability
of verification with conventional coronary angiography
Variable Odds ratio 95% CI P-value
Age 1.04 1.02 1.07 ,0.01
Male sex 2.18 1.34 3.55 ,0.01
Typical chest pain 3.09 1.47 6.50 ,0.01
Atypical chest pain 1.23 0.58 2.61 0.58
Non-specific chest pain Reference
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A P-value ,0.05 was considered statistically significant. Statisti-
cal analyses were performed using Stata/SE 10.1, StataCorp,
TX, USA.
Correction for verification bias
To correct for verification bias in our study population, we per-
formed inverse probability weighting on each individual in our
data set, using the probability of verification.
For this purpose, we used registry data12,13 of 471 outpatients
who presented to the cardiologist for the evaluation of chest
pain. All patients in this registry were intended to undergo both
stress-ECG and CT coronary angiography. Of the 471 patients,
98 were referred for CCA based on clinical parameters and the
non-invasive test results.
A logistic regression analysis was performed, predicting the
probability of undergoing CCA based on age, sex and type of
chest pain (Table A2). Subsequently, the probability of verification
was calculated for each individual in the CAD Consortium. The
inverse of the probability of verification was used to weigh each
individual, which corrects for verification bias.
Reclassification
To assess the clinical utility of the updated Diamond–Forres-
ter model, we assessed reclassification of patients between
the ages of 30 and 69 for men (Table A4, A5) and women
(Table A6, A7) separately, comparing the original Diamond–
Forrester probability prediction (i.e. according to age category,
sex, and type of chest pain) with the updated model in the
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Table A5 Reclassification table using probability categories <40 and ≥40% (men)
Probability category based on
Diamond and Forrester
Probability category based on updated
model
Total
0–40% 40–100%
0–40%
n (%) 150 (67.0) 74 (33.0) 224 (19.3)
Observed probability, % 26.0 54.1 35.5
40–100%
n (%) 22 (2.4) 913 (97.6) 935 (80.7)
Observed probability, % 27.3 73.5 72.4
Total
n (%) 172 (14.8) 987 (85.2) 1159 (100.0)
Observed probability, % 26.2 72.0 65.2
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Table A4 Reclassification table using probability categories <30, ≥30–70, and ≥70% (men)
Probability category based on
Diamond and Forrester
Probability category based on updated model Total
0–30% 30–70% 70–100%
0–30%
n (%) 62 (27.7) 162 (72.3) — 224 (19.3)
Observed probability, % 17.7 42.0 — 35.3
30–70%
n (%) — 294 (100.0) — 294 (25.4)
Observed probability, % — 48.3 48.3
70–100%
n (%) — 25 (3.9) 616 (96.1) 641 (55.3)
Observed probability, % — 64.0 84.3 83.5
Total
n (%) 62 (5.4) 481 (41.5) 616 (53.2) 1159 (100.0)
Observed probability, % 17.7 47.0 84.3 65.2
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Table A7 Reclassification table using probability categories <40 and ≥40% (women)
Probability category based on
Diamond and Forrester
Probability category based on updated
model
Total
0–40% 40–100%
0–40%
n (%) 198 (100.0) — 198 (37.8)
Observed probability, % 19.7 — 19.7
40–100%
n (%) 105 (32.2) 221 (67.8) 326 (62.2)
Observed probability, % 32.4 48.9 43.6
Total
n (%) 303 (57.8) 221 (42.2) 524 (100.0)
Observed probability, % 24.1 48.9 34.5
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Table A8 Reclassification statistics
Cutoffs Overall reclassification
percentage
%Correcta x2
model 1b
P-value x2
model 2c
P-value NRId, % P-value
for NRI
,30, ≥30–70, ≥70% Men 16.1 100.0 125.5 0 10.9 0.01 214 ,0.001
Women 64.1 100.0 261.7 0 4.25 0.12 219 0.02
,40, ≥40% Men 8.3 100.0 99.1 0 6.98 0.03 0 0.99
Women 20.0 100.0 24.0 0 4.0 0.04 2 0.64
NRI, net reclassification improvement.
aIf the predicted probability of obstructive CAD of the updated model was closer to the observed probability of CAD compared with the prediction of the original model, the
reclassification was considered to be correct.
bReclassification calibration (Hosmer–Lemeshow) statistic for the original model, using cells from the reclassification table with at least 20 observations. The significant P-value
indicates poor calibration of the original model.
cReclassification calibration statistic for the updated model, using cells from the reclassification table with at least 20 observations. The higher P-value indicates better fit of the
updated model compared with the original model.
dThe net reclassification improvement is defined as the difference in proportions of patients moving up and down for cases and non-cases separately and it is interpreted as the
percentage reclassified, adjusted for the reclassification direction. Here, the net reclassification index is negative because, on average, most individuals are being downclassified by
the updated model (i.e. less overestimation by the updated model compared with the Diamond–Forrester model), irrespective or their disease status.
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Table A6 Reclassification table using probability categories <30, ≥30–70, and ≥70% (women)
Probability category based on
Diamond and Forrester
Probability category based on updated model Total
0–30% 30–70% 70–100%
0–30%
n (%) 136 (100.0) — — 136 (25.9)
Observed probability, % 17.6 — — 17.6
30–70%
n (%) 122 (70.1) 52 (29.9) — 174 (33.2)
Observed probability, % 27.0 36.5 — 29.9
70–100%
n (%) — 214 (100.0) — 214 (40.8)
Observed probability, % — 49.1 — 49.1
Total
n (%) 258 (49.2) 266 (50.8) — 524 (100.0)
Observed probability, % 22.1 46.6 — 34.5
T.S.S. Genders et al.1328
online calculator [i.e. according to age (continuous), sex and
type of chest pain; Table A3, Model 3].
Validation of the updated model
The CAD Consortium population is highly selected based on
referral to CCA. To assess the performance of the updated
model in a lower risk population, we attempted to validate the
model in an independent registry data set (not included in our con-
sortium) consisting of unselected outpatients presenting to the
cardiologist who were intended to undergo both stress-ECG and
CCTA for the evaluation of chest pain.12,13 (This data set was
also used to perform the correction for verification bias.)
For this purpose, we followed the step-wise approach as
described above (Table A9). Since not all patients in this population
underwent CCA, the CCTA results were used as proxy for the
reference standard in patients who did not undergo CCA. Out
of 471 patients, 17 did not undergo either CCTA or CCA and
were therefore excluded from the analysis.
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Saphenous vein graft aneurysm connected to lung parenchyma: a very
unusual cause of haemoptysis
Juan Jime´nez-Ja´imez*, Eduardo Molina, and Rafael Melgares
Cardiology Department, Virgen de las Nieves Universitary Hospital, Granada, Spain
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A 74-year-old man, with a coronary
artery bypass surgery 12 years
before, was referred for a life-
threatening episode of haemoptysis.
Chest X-ray showed mild cardiome-
galy and a right pulmonary mass
(Panel A, arrow) located close to
the pulmonary hilum. Computed
tomography angiogram (Panel B)
demonstrated an aortic pseudoa-
neurysm with thrombus (arrow)
placed at the proximal anastomosis
of a saphenous vein graft to circum-
flex artery that was occluded. Three-
dimensional computed tomography
reconstruction (Panel C) showed
the anterolateral position of the
aneurysm (long arrow) that was con-
nected to lung parenchyma (short
arrow) with no evidence of aorto-
bronchial fistula. This was also
observed in aortography where we
could appreciate complete absence
of blood flow to lung or bronchi
after injection of contrast (Panel D).
Surgery was performed and intrao-
peratory transoesophageal echocar-
diography showed the ascending
aortic dilatation (Panel E); Panels F
and G show the large saphenous vein graft aneurysm at the proximal anastomosis connected to lung parenchyma corrected with a
Gore Tex patch.
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